<DOC>
	<DOCNO>NCT01830959</DOCNO>
	<brief_summary>Pulmonary sarcoidosis patient fibrosis often develop recurrent episode bronchitis . These lead worsening disease short long term . Roflumilast show reduce number acute bronchitis episodes patient COPD . Drugs similar Roflumilast show help sarcoidosis . The current study determine Roflumilast reduce number episode bronchitis help fibrotic sarcoidosis .</brief_summary>
	<brief_title>Use Roflumilast Prevent Exacerbations Fibrotic Sarcoidosis Patients ( REFS )</brief_title>
	<detailed_description>This multicenter , double blind , placebo control study . Patients would randomize 1:1 receive either roflumilast 500 mcg per day placebo add current treatment regimen twelve month .</detailed_description>
	<mesh_term>Sarcoidosis</mesh_term>
	<criteria>1 . Patients sarcoidosis define American Thoracic Society criteria 2 . Patients FEV1/FVC ratio le 80 % 3 . Patients fibrosis chest xray and/or high resolution CT scan . 4 . Patients least two exacerbation sarcoidosis prior year . An exacerbation define acute event require increase prednisone without use antibiotic . 5 . Patients must stable dose corticosteroid agent sarcoidosis least 4 week prior first visit . 6 . For patient prednisone alone , dose equivalent 5 mg prednisone day . For immunosuppressant , dose prednisone . 7 . Patients must age 18 70 year age . 8 . Willing take prednisone increase dosage exacerbation sarcoidosis . 9 . Patients must able provide write informed consent participate study . 1 . Patients know hypersensitivity theophylline pentoxifylline eligible . Patients dose dependent nausea drug may still participate trial . 2 . Patients able take theophylline pentoxifylline time study . They allow take drug sarcoidosis include prednisone , methotrexate , azathioprine , leflunomide , hydroxychloroquine , thalidomide , infliximab , adalimumab , rituximab . 3 . Patients serum creatinine great 3 mg/dL 4 . Patients moderate severe liver disease define Child Pugh class 3 4 . 5 . Patients unstable cardiac disease 6 . Patients non cutaneous malignancy treat past two year . 7 . Patients unable complete questionnaire six minute walk detail study.Women child bear potential unable use adequate birth control determine investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Sarcoidosis , fibrosis , bronchiectasis</keyword>
</DOC>